Dr. Robert W. Given , MD
Urology • Virginia Beach, VA
225 Clearfield Ave
Virginia Beach, VA 234621815
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 9, 2006; this date does not establish years in practice.
-
Published CMS data list 35,809 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J9030 — Bcg live intravesical instillation, 1 mg: 12,436 service units.
- J0897 — Injection, denosumab, 1 mg: 7,800 service units.
- J1952 — Leuprolide injectable, camcevi, 1 mg: 4,242 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 41 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,453 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 406 prescription fills, including refills.
- Erleada (Apalutamide) — 202 prescription fills, including refills.
- Abiraterone Acetate — 104 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 20 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Virginia Beach, VA (2024, 21 clinicians with data). Median for this group: 5,533. Middle half: 2,081 to 7,934.
More Medicare Part B services than 95% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: 2,306. Middle half: 766 to 5,298.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 47,043 in 2020 to 35,809 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
225 Clearfield Ave
Virginia Beach, VA 234621815
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Urology Of Virginia, Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Virginia Commonwealth University, School Of Medicine
1988
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,681 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $928,479 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $729,253 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,458 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$5,801,670 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $37,134.37 across 95 records.
By nature of payment (3 largest of 6)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $23,043.00 across 9 records.
- Travel and Lodging: $7,130.46 across 15 records.
- Food and Beverage: $2,445.31 across 68 records.
Reporting-company totals (3 largest of 13)
- Bayer Healthcare Pharmaceuticals Inc.: $15,709.49 across 29 records.
- Janssen Pharmaceuticals, Inc: $14,573.07 across 23 records.
- AVYXA PHARMA, LLC: $3,360.75 across 5 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
38 years (graduated 1988)
CMS Doctors and Clinicians data list 1988 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Given has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Given as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Virginia Beach and Virginia
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Virginia Beach, VA (2024, 21 clinicians with data). Median for this group: 5,533. Middle half: 2,081 to 7,934.
More Medicare Part B services than 95% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: 2,306. Middle half: 766 to 5,298.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Virginia Beach, VA (2024, 21 clinicians with data). Median for this group: $513,522. Middle half: $159,209 to $568,731.
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: $176,111. Middle half: $72,177 to $296,677.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Virginia Beach, VA (2024, 21 clinicians with data). Median for this group: $390,548. Middle half: $123,073 to $436,926.
A higher Medicare payment amount than 95% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: $131,847. Middle half: $54,881 to $222,518.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Urology in Virginia Beach, VA (2024, 21 clinicians with data). Median for this group: 935. Middle half: 282 to 1,383.
More Part D prescriptions than 65% of clinicians listed under Urology in Virginia (2024, 234 clinicians with data). Median for this group: 966. Middle half: 304 to 1,617.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Virginia Beach, VA (2024, 21 clinicians with data). Median for this group: $46,596. Middle half: $7,725 to $122,726.
A higher Part D drug cost than 95% of clinicians listed under Urology in Virginia (2024, 234 clinicians with data). Median for this group: $86,734. Middle half: $15,005 to $302,997.
36 active clinicians are listed under Urology with a practice address in Virginia Beach, VA (359 in Virginia).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Virginia Beach
50% of these 36 clinicians have the CMS telehealth indicator.
72.2% of these 36 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 24% from 47,043 in 2020 to 35,809 in 2024.
- 2020: 47,043
- 2021: 50,136
- 2022: 42,897
- 2023: 35,694
- 2024: 35,809
-
Medicare-allowed amount
Medicare-allowed amount increased 22% from $759,663 in 2020 to $928,479 in 2024.
- 2020: $759,663
- 2021: $826,884
- 2022: $812,446
- 2023: $670,805
- 2024: $928,479
-
Paid by Medicare
Paid by Medicare increased 22% from $595,860 in 2020 to $729,253 in 2024.
- 2020: $595,860
- 2021: $639,928
- 2022: $619,077
- 2023: $516,592
- 2024: $729,253
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 49% from 975 in 2020 to 1,453 in 2024.
- 2020: 975
- 2021: 1,216
- 2022: 1,074
- 2023: 950
- 2024: 1,453
-
30-day fills
30-day fills increased 31% from 1,876 in 2020 to 2,458 in 2024.
- 2020: 1,876
- 2021: 2,212
- 2022: 1,983
- 2023: 1,707
- 2024: 2,458
-
Part D drug cost
Part D drug cost increased 108% from $2,786,806 in 2020 to $5,801,670 in 2024.
- 2020: $2,786,806
- 2021: $4,340,126
- 2022: $3,624,933
- 2023: $2,736,970
- 2024: $5,801,670
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 235% from $17,259.81 in 2021 to $57,874.98 in 2025.
- 2021: $17,259.81
- 2022: $11,297.79
- 2023: $19,321.90
- 2024: $10,692.01
- 2025: $57,874.98
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 97 records totaling $57,874.98.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Dendreon Pharmaceuticals LLC |
General
Cash or cash equivalent
|
PROVENGE | Research | $20,090.61 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RYBREVANT | General | $4,717.50 |
| Bayer Healthcare Pharmaceuticals Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Nubeqa | General | $4,410.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RYBREVANT | General | $4,162.50 |
| Bayer Healthcare Pharmaceuticals Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Nubeqa | General | $3,822.00 |
| UROGEN PHARMA, INC. |
Honoraria
Cash or cash equivalent
|
ZUSDURI | General | $2,275.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,232.00 |
| AVYXA PHARMA, LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $2,000.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Travel and Lodging
In-kind items and services
|
Nubeqa | General | $1,591.15 |
| Bayer Healthcare Pharmaceuticals Inc. |
Travel and Lodging
In-kind items and services
|
Nubeqa | General | $1,200.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Nubeqa | General | $1,176.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RYBREVANT | General | $1,100.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RYBREVANT | General | $1,100.00 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
RYBREVANT | General | $802.85 |
| AVYXA PHARMA, LLC |
Travel and Lodging
In-kind items and services
|
— | General | $681.72 |
| Dendreon Pharmaceuticals LLC |
General
Cash or cash equivalent
|
PROVENGE | Research | $650.00 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
RYBREVANT | General | $640.32 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RYBREVANT | General | $555.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Travel and Lodging
In-kind items and services
|
— | General | $551.78 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
RYBREVANT | General | $544.68 |
| AVYXA PHARMA, LLC |
Travel and Lodging
In-kind items and services
|
— | General | $411.97 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
RYBREVANT | General | $217.80 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
RYBREVANT | General | $214.23 |
| Bayer Healthcare Pharmaceuticals Inc. |
Travel and Lodging
In-kind items and services
|
— | General | $194.78 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
ZUSDURI | General | $180.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J9030
Bcg live intravesical instillation, 1 mg
|
12,436 | 73 | $7.00 | $2.86 |
|
J0897
Injection, denosumab, 1 mg
|
7,800 | 51 | $45.00 | $25.89 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
4,242 | 97 | $119.00 | $55.77 |
|
J9155
Injection, degarelix, 1 mg
|
3,120 | 16 | $10.00 | $4.20 |
|
81003
Automated urinalysis test
|
1,101 | 663 | $11.00 | $2.17 |
|
84153
Psa (prostate specific antigen) measurement, total
|
1,001 | 623 | $70.00 | $17.73 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
898 | 675 | $270.00 | $123.23 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
850 | 667 | $32.00 | $15.96 |
|
36415
Insertion of needle into vein for collection of blood sample
|
716 | 633 | $32.00 | $8.50 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
580 | 67 | $84.00 | $59.97 |
|
84403
Testosterone (hormone) level, total
|
375 | 209 | $75.00 | $25.01 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
276 | 71 | $870.00 | $174.78 |
|
51720
Instillation of anti-cancer drug into bladder
|
269 | 78 | $295.00 | $85.71 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
259 | 242 | $190.00 | $88.15 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
214 | 178 | $145.00 | $34.12 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
195 | 136 | $555.00 | $231.33 |
|
82306
Vitamin d-3 level
|
179 | 128 | $84.00 | $28.49 |
|
87186
Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution
|
161 | 107 | $30.00 | $8.48 |
|
87086
Bacterial colony count, urine
|
158 | 105 | $35.00 | $7.91 |
|
87088
Bacterial urine culture
|
158 | 105 | $45.00 | $7.93 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
125 | 111 | $360.00 | $175.61 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
87 | 83 | $55.00 | $10.96 |
|
96372
Injection of drug or substance under skin or into muscle
|
82 | 57 | $70.00 | $13.98 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
80 | 20 | $2.00 | $0.43 |
|
99231
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
|
63 | 56 | $77.00 | $47.59 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 406 | 31,937 | $5,361.81 | 153 |
| Erleada | Apalutamide | 202 | 6,390 | $3,017,248.46 | 36 |
| Abiraterone Acetate | Abiraterone Acetate | 104 | 3,120 | $157,808.12 | 19 |
| Xtandi | Enzalutamide | 88 | 2,640 | $1,162,816.57 | 22 |
| Nubeqa | Darolutamide | 88 | 2,880 | $1,203,448.98 | 16 |
| Prednisone | Prednisone | 83 | 2,521 | $381.51 | 17 |
| Finasteride | Finasteride | 83 | 6,536 | $1,128.16 | 28 |
| Orgovyx | Relugolix | 81 | 2,430 | $234,385.00 | 17 |
| Cephalexin | Cephalexin | 55 | 342 | $268.38 | 42 |
| Trospium Chloride | Trospium Chloride | 46 | 2,585 | $2,444.94 | 16 |
| Levofloxacin | Levofloxacin | 45 | 84 | $74.83 | 39 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 30 | 2,580 | $556.69 | — |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | 1,575 | $502.24 | — |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 23 | 63 | $59.41 | 21 |
| Dutasteride | Dutasteride | 20 | 1,290 | $592.37 | — |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 118 | $99.82 | 14 |
| Myrbetriq | Mirabegron | 16 | 900 | $13,514.23 | — |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | 780 | $452.64 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 97 | $112.86 | 13 |
| Bicalutamide | Bicalutamide | 13 | 720 | $413.27 | 11 |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20060803000472
VA
8426021403
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Urology Of Virginia, Pllc
229 Clearfield Ave, Virginia Beach, VA 234621815
Phone: 7574575177
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated January 09, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Virginia Beach
- Dr. Jeremy Tonkin, MD
- Dr. Ramon Virasoro, MD
- Dr. Edwin Epstein, MD
- Dr. John Malcolm, MD
- Dr. Joshua Langston, MD
- Dr. Bruce Rosenfeld, MD
Mailing Address
225 Clearfield Ave
Virginia Beach, VA 234621815
Phone: 7574575177